126 related articles for article (PubMed ID: 23921444)
1. Targeted antifungal prophylaxis in heart transplant recipients.
Muñoz P; Valerio M; Palomo J; Giannella M; Yañez JF; Desco M; Bouza E
Transplantation; 2013 Oct; 96(7):664-9. PubMed ID: 23921444
[TBL] [Abstract][Full Text] [Related]
2. Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Kabbani D; Goldraich L; Ross H; Rotstein C; Husain S
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125713
[TBL] [Abstract][Full Text] [Related]
3. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
5. Antifungal Prophylaxis in Lung Transplant Recipients.
Patel TS; Eschenauer GA; Stuckey LJ; Carver PL
Transplantation; 2016 Sep; 100(9):1815-26. PubMed ID: 26950711
[TBL] [Abstract][Full Text] [Related]
6. Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy Strategy.
Herrera S; Davoudi S; Farooq A; Tikkanen J; Foroutan F; Kumar D; Humar A; Rotstein C; Singer LG; Keshavjee S; Husain S
Transplantation; 2020 Dec; 104(12):2575-2581. PubMed ID: 32080158
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
8. Invasive aspergillosis among heart transplant recipients: a 24-year perspective.
Muñoz P; Cerón I; Valerio M; Palomo J; Villa A; Eworo A; Fernández-Yáñez J; Guinea J; Bouza E
J Heart Lung Transplant; 2014 Mar; 33(3):278-88. PubMed ID: 24559945
[TBL] [Abstract][Full Text] [Related]
9. Long-term pulmonary infections in heart transplant recipients.
Küpeli E; Ulubay G; Akkurt ES; Öner Eyüboğlu F; Sezgin A
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():356-60. PubMed ID: 25894190
[TBL] [Abstract][Full Text] [Related]
10. Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
Hayes D; Ball AM; Mansour HM; Martin CA; Flynn JD
Exp Clin Transplant; 2011 Dec; 9(6):399-404. PubMed ID: 22142048
[TBL] [Abstract][Full Text] [Related]
11. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
12. Fungal infections and antifungal prophylaxis in pediatric cardiac extracorporeal life support.
Gardner AH; Prodhan P; Stovall SH; Gossett JM; Stern JE; Wilson CD; Fiser RT
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):689-95. PubMed ID: 22177096
[TBL] [Abstract][Full Text] [Related]
13. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
Saliba F; Delvart V; Ichaï P; Kassis N; Botterel F; Mihaila L; Azoulay D; Adam R; Castaing D; Bretagne S; Samuel D
Med Mycol; 2013 Feb; 51(2):155-63. PubMed ID: 22800082
[TBL] [Abstract][Full Text] [Related]
14. High-dose weekly liposomal amphotericin b antifungal prophylaxis in patients undergoing liver transplantation: a prospective phase II trial.
Giannella M; Ercolani G; Cristini F; Morelli M; Bartoletti M; Bertuzzo V; Tedeschi S; Faenza S; Puggioli C; Lewis RE; Pinna AD; Viale P
Transplantation; 2015 Apr; 99(4):848-54. PubMed ID: 25531982
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
16. The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant.
Hosseini-Moghaddam SM; Chaparro C; Luong ML; Azad S; Singer LG; Mazzulli T; Rotstein C; Keshavjee S; Husain S
Transplantation; 2015 Nov; 99(11):2387-93. PubMed ID: 25961491
[TBL] [Abstract][Full Text] [Related]
17. Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
Aguilar CA; Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Ussetti P; Chin-Hong PV; Sole A; Holmes-Liew C; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Singer LG; Husain S
J Heart Lung Transplant; 2018 Oct; 37(10):1226-1234. PubMed ID: 30139546
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.
Winston DJ; Bartoni K; Territo MC; Schiller GJ
Biol Blood Marrow Transplant; 2011 Apr; 17(4):507-15. PubMed ID: 20460163
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
[TBL] [Abstract][Full Text] [Related]
20. Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.
Sun HY; Cacciarelli TV; Singh N
Transplantation; 2013 Sep; 96(6):573-8. PubMed ID: 23842191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
